IPO registrations (S-1, F-1) · Registrants
INVERESK RESEARCH GROUP INC
- SEC CIK
- 1169358 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2002-04-02, last 2003-02-18; 2 initial registrations, 4 amendments
- Outcome
- Final prospectus filed 2002-06-28; withdrawal requested 2003-03-07
- Industry (SIC)
- Services-Commercial Physical & Biological Research 8731
- Incorporated in
- DE
- Business address
- 11000 WESTON PARKWAY, SUITE 100, Cary, NC 27513
- EIN
- 43-1955097
- EDGAR entity type
- operating
Offering terms
- Proposed price range
- $14.00–$16.00 per share (S-1/A filed 2002-06-27)
- Final price
- $13.00 per share, below the range (424B4 filed 2002-06-28, an initial public offering)
- Shares sold
- 12,000,000
- Gross proceeds
- $156,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol IRGI
- Lead underwriters
- Bear Stearns; UBS (3,532,800 shares)
- Syndicate
- William Blair (883,200); Cowen (883,200); BofA Securities (120,000); Merrill Lynch (120,000); Prudential Securities (120,000); Thomas Weisel Partners (120,000); Chatsworth Securities LLC (60,000); Gerard Klauer Mattison & Co., LLC (60,000); Investec PMG Capital Corp (60,000); Jefferies (60,000); Ladenburg Thalmann (60,000); Leerink Partners (60,000); Raymond James (60,000); Redwine & Company Inc (60,000)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
Filings 10
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2002-04-02 | S-1 | S-1 (registration) | INVERESK RESEARCH GROUP INC | 0000950123-02-003315 ↗ |
| 2002-05-14 | S-1/A | S-1/A (amendment) | INVERESK RESEARCH GROUP INC | 0000950123-02-005155 ↗ |
| 2002-06-05 | S-1/A | S-1/A (amendment) | INVERESK RESEARCH GROUP INC | 0000950123-02-005917 ↗ |
| 2002-06-21 | S-1/A | S-1/A (amendment) | INVERESK RESEARCH GROUP INC | 0000950123-02-006380 ↗ |
| 2002-06-27 | S-1/A | S-1/A (amendment) | INVERESK RESEARCH GROUP INC | 0000950123-02-006564 ↗ |
| 2002-06-28 | 424B4 | 424B4 (final prospectus) | INVERESK RESEARCH GROUP INC | 0000950123-02-006584 ↗ |
| 2003-02-18 | S-1 | S-1 (registration) | INVERESK RESEARCH GROUP INC | 0000950123-03-001652 ↗ |
| 2003-03-07 | RW | RW (withdrawal request) | INVERESK RESEARCH GROUP INC | 0000950123-03-002553 ↗ |
| 2003-11-20 | 424B4 | 424B4 (final prospectus) | INVERESK RESEARCH GROUP INC | 0000950123-03-012987 ↗ |
| 2004-04-02 | 424B4 | 424B4 (final prospectus) | INVERESK RESEARCH GROUP INC | 0000950123-04-004187 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2002-06-27 | S-1/A | registration statement | $14.00–$16.00 | $15.00 | 12,000,000 | $180,000,000 | Nasdaq IRGI | 5 | primary document; range, price sentence, shares headline, proceeds computed, underwriting table 1, cover names 4 | document ↗ |
| 2002-06-28 | 424B4 | final prospectus | $13.00 | 12,000,000 | $156,000,000 | Nasdaq IRGI | 16 | primary document; price sentence, shares headline, proceeds table, underwriting table 15, cover names 4 | document ↗ |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Others with the same interests
SIC industry Services-Commercial Physical & Biological Research, NC first:
- Icoria, Inc. NC
- PRA International, LLC NC
- IQVIA HOLDINGS INC. NC
- Icagen, Inc. NC
- Syneos Health, Inc. NC
- PRA Health Sciences, Inc. NC
- PPD, Inc. NC
- Science 37 Holdings, Inc. NC
- WEED, INC. AZ
- GLYCOTEX, INC. C3
In other datasets, the same topic (Medical research) in NC:
- Form D issuer: 22nd Century Group, Inc. (Form D private offerings)
- Nonprofit: 3000 MILES FOR AUTISM (Nonprofits (IRS Form 990))
Interests: Services-Commercial Physical & Biological Research · Medical research